Melioidosis of the central nervous system: Impact of the bimABm allele on patient presentation and outcome

Hannah Gora, Tasnim Hasan, Simon Smith, Ian Wilson, Mark Mayo, Celeste Woerle, Jessica R Webb, Bart J Currie, Josh Hanson, Ella M Meumann

Research output: Contribution to journalArticlepeer-review

Abstract

Background
The autotransporter protein Burkholderia intracellular motility A (BimA) facilitates the entry of Burkholderia pseudomallei into the central nervous system (CNS) in mouse models of melioidosis. Its role in the pathogenesis of human cases of CNS melioidosis is incompletely defined.

Methods
Consecutive culture-confirmed cases of melioidosis at two sites in tropical Australia after 1989 were reviewed. Demographic, clinical and radiological data of the patients with CNS melioidosis were recorded. The bimA allele (bimABm or bimABp) of the B. pseudomallei isolated from each patient was determined.

Results
Of the 1587 cases diagnosed at the two sites during the study period, 52 (3.3%) had confirmed CNS melioidosis; 20 (38.5%) had a brain abscess, 18 (34.6%) had encephalomyelitis, 4 (7.7%) had isolated meningitis and 10 (19.2%) had extra-meningeal disease. Among the 52 patients, there were 8 (15.4%) deaths; 17/44 (38.6%) survivors had residual disability. The bimA allele was characterized in 47/52; 17/47 (36.2%) had the bimABm allele and 30 (63.8%) had the bimABp allele. Patients with a bimABm variant were more likely to have a predominantly neurological presentation (odds ratio (OR) (95% confidence interval (CI)): 5.60 (1.52-20.61), p=0.01), to have brainstem involvement (OR (95%CI): 7.33 (1.92-27.95), p=0.004) and to have encephalomyelitis (OR (95%CI): 4.69 (1.30-16.95), p=0.02. Patients with a bimABm variant were more likely to die or have residual disability (odds ratio (95%CI): 4.88 (1.28-18.57), p=0.01).

Conclusions
The bimA allele of B. pseudomallei has a significant impact on the clinical presentation and outcome of patients with CNS melioidosis.
Original languageEnglish
Pages (from-to)1-23
Number of pages23
JournalClinical Infectious Diseases
Early online date7 Feb 2022
DOIs
Publication statusE-pub ahead of print - 7 Feb 2022

Fingerprint

Dive into the research topics of 'Melioidosis of the central nervous system: Impact of the bimABm allele on patient presentation and outcome'. Together they form a unique fingerprint.

Cite this